The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease
Open accessAbstract
Interactions of the presynaptic proteins, neuronal pentraxin 2 (NPTX2) and neurexin 2α (NRXN22α), with their respective postsynaptic functional partners, GluA4‐containing glutamate (AMPA4) receptor and neuroligin 1 (NLGN1), enhance excitatory synaptic activity in some areas of the hippocampus and cerebral cortex. As early damage of such excitatory circuits in the brain tissues of participants with Alzheimer's disease (AD) correlates with cognitive losses, plasma neuron‐derived exosome (NDE) levels of these 2 pairs of specialized synaptic proteins were quantified to assess their biomarker characteristics. The NDE contents of all 4 proteins were decreased significantly in AD dementia ( n = 46), and diminished levels of AMPA4 and NLGN1 correlated with the extent of cognitive loss. In a preclinical period, 6–11 yr before the onset of dementia, the NDE levels of all but NPTX2 were significantly lower than those of matched controls, and levels of all proteins declined significantly with the development of dementia. Reductions in NDE levels of these specialized excitatory synaptic proteins may therefore be indicative of the extent of cognitive loss and may reflect progression of the severity of AD.—Goetzl, E. J., Abner, E. L., Jicha, G. A., Kapogiannis, D., Schwartz, J. B. Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease. FASEB J. 32, 888–893 (2018). www.fasebj.org
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A study on plasma neuronal exosomes of patients with AD dementia revealed declined levels of NPTX2 compared with matched controls.”
From Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration (2022) · cites this paper as Goetzl et al. 2018
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70178-3 · Cited by 4,411
Self-citationTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
Shaw, L. M., Vanderstichele, H., Knapik‐Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21610 · Cited by 2,065
Neuroligins and neurexins link synaptic function to cognitive disease
Südhof, T. C. (2008) · Nature · doi:10.1038/nature07456 · Cited by 1,849 · cited 1×
“Presynaptic neurexin2a (NRXN2a) and the postsynaptic adhesion protein, neuroligin1 (NLGN1), interact trans-synaptically to ensure structural stability and functions of excitatory synapses in the hippocampus and cortex (6, 7).”
BackgroundMustapic, M., Eitan, E., Werner, J. K., Berkowitz, S. T., Lazaropoulos, M. P., Tran, J., Goetzl, E. J., & Kapogiannis, D. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00278 · Cited by 441
Self-citation
Cited by
Sorted by citations
Circulating Extracellular Vesicles in Human Disease
Shah, R. V., Patel, T. C., & Freedman, J. E. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1704286 · Cited by 765
Therapeutically harnessing extracellular vesicles
Cheng, L., & Hill, A. F. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00410-w · Cited by 737
Targeting and Crossing the Blood-Brain Barrier with Extracellular Vesicles
Saint-Pol, J., Gosselet, F., Duban-Deweer, S., Pottiez, G., & Karamanos, Y. (2020) · Cells · doi:10.3390/cells9040851 · Cited by 503
Extracellular Vesicles and Neurodegenerative Diseases
Hill, A. F. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.0147-18.2019 · Cited by 437
High complement levels in astrocyte‐derived exosomes of Alzheimer disease
Goetzl, E. J., Schwartz, J. B., Abner, E. L., Jicha, G. A., & Kapogiannis, D. (2018) · Annals of Neurology · doi:10.1002/ana.25172 · Cited by 373
Self-citationExtracellular vesicles through the blood–brain barrier: a review
Ramos‐Zaldívar, H. M., Polakovičová, I., Salas‐Huenuleo, E., Corvalán, A. H., Kogan, M. J., Yefi, C. P., & Andía, M. E. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00359-3 · Cited by 320
L1CAM is not associated with extracellular vesicles in human cerebrospinal fluid or plasma
Norman, M., Ter‐Ovanesyan, D., Trieu, W., Lazarovits, R., Kowal, E. J. K., Lee, J.-H., Chen‐Plotkin, A. S., Regev, A., Church, G. M., & Walt, D. R. (2021) · Nature Methods · doi:10.1038/s41592-021-01174-8 · Cited by 261
Pulliam, L., Sun, B., Mustapić, M., Chawla, S., & Kapogiannis, D. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-018-0695-4 · Cited by 246
Self-citationKapogiannis, D., Mustapic, M., Shardell, M. D., Berkowitz, S. T., Diehl, T. C., Spangler, R. D., Tran, J., Lazaropoulos, M. P., Chawla, S., Gulyani, S., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.2462 · Cited by 241
Self-citationMesenchymal stem cell-derived exosome: a promising alternative in the therapy of Alzheimer’s disease
Guo, M., Yin, Z., Chen, F., & Lei, P. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00670-x · Cited by 205
Sun, B., Tang, N., Peluso, M. J., Iyer, N. S., Torres, L., Donatelli, J. L., Munter, S. E., Nixon, C. C., Rutishauser, R. L., Rodríguez-Barraquer, I., et al. (2021) · Cells · doi:10.3390/cells10020386 · Cited by 190
Detection of Aggregation-Competent Tau in Neuron-Derived Extracellular Vesicles
Guix, F. X., Corbett, G. T., Cha, D., Mustapić, M., Liu, W., Mengel, D., Chen, Z., Aïkawa, E., Young‐Pearse, T. L., Kapogiannis, D., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030663 · Cited by 186
Self-citationFluid Biomarkers for Synaptic Dysfunction and Loss
Camporesi, E., Nilsson, J., Brinkmalm, A., Becker, B., Ashton, N. J., Blennow, K., & Zetterberg, H. (2020) · Biomarker Insights · doi:10.1177/1177271920950319 · Cited by 165
New windows into the brain: Central nervous system-derived extracellular vesicles in blood
Shi, M., Sheng, L., Stewart, T., Zabetian, C. P., & Zhang, J. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.01.005 · Cited by 181
Diagnostic and therapeutic potential of exosomes in Alzheimer’s disease
Martins, T. S., Trindade, D., Vaz, M., Campelo, I., Almeida, M., Trigo, G., Silva, O. A. B. D. C. E., & Henriques, A. G. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15112 · Cited by 177
Exosome Determinants of Physiological Aging and Age-Related Neurodegenerative Diseases
D’Anca, M., Fenoglio, C., Serpente, M., Arosio, B., Cesari, M., Scarpini, E. A., & Galimberti, D. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00232 · Cited by 154
Stem Cell-Derived Exosomes: a New Strategy of Neurodegenerative Disease Treatment
Hosseini, N. F., Sheykhhasan, M., Asl, S. S., & Najafi, R. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02324-x · Cited by 155
Huo, L., Du, X., Li, X., Liu, S., & Xu, Y. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.738442 · Cited by 149
The emerging role of exosomes in Alzheimer’s disease
Zhang, T., Ma, S., Lv, J., Wang, X., Afewerky, H. K., Li, H. R., & Lu, Y. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101321 · Cited by 141
Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases
Fan, Y., Chen, Z., & Zhang, M. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03493-6 · Cited by 134
Propagation of Tau via Extracellular Vesicles
Pérez, M., Avila, J., & Hernández, F. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00698 · Cited by 118
Winston, C. N., Goetzl, E. J., Schwartz, J. B., Elahi, F. M., & Rissman, R. A. (2018) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.11.002 · Cited by 120
Self-citationSARS‐CoV‐2 and Mitochondrial Proteins in Neural‐Derived Exosomes of COVID‐19
Peluso, M. J., Deeks, S. G., Mustapić, M., Kapogiannis, D., Henrich, T. J., Lu, S., Goldberg, S. A., Hoh, R., Chen, J. Y., Martinez, E. O., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26350 · Cited by 116
Self-citationGómez de San José, N., Massa, F., Halbgebauer, S., Oeckl, P., Steinacker, P., & Otto, M. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-021-02411-2 · Cited by 112
Winston, C. N., Romero, H. K., Ellisman, M., Nauss, S., Julovich, D. A., Conger, T., Hall, J. R., Campana, W., O’Bryant, S. E., Nievergelt, C. M., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01005 · Cited by 105
Extracellular Vesicles in neural cell interaction and CNS homeostasis
Schnatz, A., Müller, C., Brahmer, A., & Krämer‐Albers, E. (2021) · FASEB BioAdvances · doi:10.1096/fba.2021-00035 · Cited by 112
Saeedi, S., Nagy, C., Ibrahim, P., Théroux, J., Wakid, M., Fiori, L. M., Yang, J., Rotzinger, S., Foster, J. A., Mechawar, N., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01255-2 · Cited by 110
Brain Derived Exosomes Are a Double-Edged Sword in Alzheimer’s Disease
Song, Z., Xu, Y., Deng, W., Zhang, L., Zhu, H., Yü, P., Qu, Y., Zhao, W., Han, Y., & Qin, C. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00079 · Cited by 103
Extracellular vesicles in the diagnosis and treatment of central nervous system diseases
Rizvanov, A. A., Shaimardanova, A. A., Solovyeva, V. V., Chulpanova, D. S., James, V. H., & Kitaeva, K. V. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.266908 · Cited by 103
Katsu, M., Hama, Y., Utsumi, J., Takashina, K., Yasumatsu, H., Mori, F., Wakabayashi, K., Shoji, M., & Sasaki, H. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.03.048 · Cited by 99
Exosome: A novel neurotransmission modulator or non-canonical neurotransmitter?
Xia, X., Wang, Y., Qin, Y., Zhao, S., & Zheng, J. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101558 · Cited by 107
Eitan, E., Thornton‐Wells, T. A., Elgart, K., Erden, E., Gershun, E., Levine, A. A., Volpert, O. V., Azadeh, M., Smith, D. G., & Kapogiannis, D. (2023) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2023.13 · Cited by 97
Self-citationBiomarker potential of brain‐secreted extracellular vesicles in blood in Alzheimer's disease
Badhwar, A., & Haqqani, A. S. (2020) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12001 · Cited by 87
A new paradigm for diagnosis of neurodegenerative diseases: peripheral exosomes of brain origin
Younas, N., Flores, L. C. F., Hopfner, F., Höglinger, G. U., & Zerr, I. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00301-5 · Cited by 84
Shetgaonkar, G. G., Marques, S. M., DCruz, C. E. M., Vibhavari, R. J. A., Kumar, L., & Shirodkar, R. K. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01026-0 · Cited by 400
Yuan, Y., Wang, J., Zhang, Y., Li, L., Reza, A. M. M. T., & Gurunathan, S. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s407029 · Cited by 85
Tian, C., Stewart, T., Hong, Z., Guo, Z., Aro, P., Soltys, D., Pan, C., Peskind, E. R., Zabetian, C. P., Shaw, L. M. J., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12723 · Cited by 80
Emergence of Extracellular Vesicles as “Liquid Biopsy” for Neurological Disorders: Boom or Bust
Kumar, A., Nader, M. A., & Deep, G. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000788 · Cited by 79
Mustapić, M., Tran, J., Craft, S., & Kapogiannis, D. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180578 · Cited by 79
Self-citationChen, L., Liu, W., Lin, H., Lin, M., Yu, Y., Liu, H., Dai, Y., Chen, L.-W., Jia, W., He, X., et al. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335832 · Cited by 76
Neuron-derived extracellular vesicles in blood reveal effects of exercise in Alzheimer’s disease
Delgado‐Peraza, F., Nogueras‐Ortiz, C. J., Simonsen, A. H., Knight, D. D., Yao, P. J., Goetzl, E. J., Jensen, C. S., Høgh, P., Gottrup, H., Vestergaard, K., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01303-9 · Cited by 76
Self-citationNeuronally derived extracellular vesicles: an emerging tool for understanding Alzheimer’s disease
Watson, L. S., Hamlett, E. D., Stone, T. D., & Sims‐Robinson, C. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0317-5 · Cited by 75
The Basic Characteristics of the Pentraxin Family and Their Functions in Tumor Progression
Wang, Z., Wang, X., Zou, H., Dai, Z., Feng, S., Zhang, M., Xiao, G., Liu, Z., & Cheng, Q. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01757 · Cited by 73
Vandendriessche, C., Bruggeman, A., Cauwenberghe, C. V., & Vandenbroucke, R. E. (2020) · Cells · doi:10.3390/cells9112485 · Cited by 75
Cuttler, K., Hassan, M., Carr, J. A., Cloete, R. E. A., & Bardien, S. (2021) · Open Biology · doi:10.1098/rsob.210091 · Cited by 69
Wijtenburg, S. A., Kapogiannis, D., Korenic, S. A., Mullins, R. J., Tran, J., Gaston, F. E., Chen, S., Mustapić, M., Hong, L. E., & Rowland, L. M. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.01.031 · Cited by 73
Self-citationExtracellular vesicles, the emerging mirrors of brain physiopathology
Cano, A. C., Ettcheto, M., Bernuz, M., Puerta, R., Antonio, E. E., Sánchez‐López, E., Souto, E. B., Camins, A., Martí, M., Pividori, M. I., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.79063 · Cited by 75
Xu, X., Iqbal, Z., Xu, L., Wen, C., Duan, L., Xia, J., Yang, N., Zhang, Y., & Liang, Y. (2024) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13610 · Cited by 68
Exosomes: Innocent Bystanders or Critical Culprits in Neurodegenerative Diseases
Beatriz, M., Vilaça, R., & Lopes, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.635104 · Cited by 67
Promise of extracellular vesicles for diagnosis and treatment of epilepsy
Upadhya, D., & Shetty, A. K. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.106499 · Cited by 66
Neuron-Derived Plasma Exosome Proteins after Remote Traumatic Brain Injury
Goetzl, E. J., Peltz, C. B., Mustapić, M., Kapogiannis, D., & Yaffe, K. S. (2019) · Journal of Neurotrauma · doi:10.1089/neu.2019.6711 · Cited by 65
Self-citationEnrichment of extracellular vesicles using Mag-Net for the analysis of the plasma proteome
Wu, C. C., Tsantilas, K. A., Park, J., Plubell, D. L., Sanders, J. A., Naicker, P., Govender, I. S., Buthelezi, S. G., Stoychev, S., Jordaan, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60595-7 · Cited by 121
Role of Extracellular Vesicles in Amyotrophic Lateral Sclerosis
Ferrara, D., Pasetto, L., Bonetto, V., & Basso, M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00574 · Cited by 65
Diagnostic and Therapeutic Potential of Exosomes in Neurodegenerative Diseases
Gao, P., Li, X., Du, X., Liu, S., & Xu, Y. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.790863 · Cited by 61
Biomarkers in Neurodegenerative Diseases: Proteomics Spotlight on ALS and Parkinson’s Disease
Raghunathan, R., Turajane, K., & Wong, L. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169299 · Cited by 63
Extracellular vesicles as an emerging tool for the early detection of Alzheimer’s disease
Li, T.-R., Wang, X.-N., Sheng, C., Li, Y.-X., Li, F. Z.-T., Sun, Y., & Han, Y. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.111175 · Cited by 60
Wu, C. C., Tsantilas, K. A., Park, J., Plubell, D. L., Sanders, J. A., Naicker, P., Govender, I. S., Buthelezi, S. G., Stoychev, S., Jordaan, J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.10.544439 · Cited by 60
T he roles of extracellular vesicle micro RNA s in the central nervous system
Blandford, S. N., Galloway, D. A., & Moore, C. S. (2018) · Glia · doi:10.1002/glia.23445 · Cited by 62
Gomes, P., Tzouanou, F., Skolariki, K., Vamvaka-Iakovou, A., Nogueras‐Ortiz, C. J., Tsirtsaki, K., Waites, C. L., Vlamos, P., Sousa, N., Costa‐Silva, B., et al. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114183 · Cited by 60
Self-citationWang, L., Zhang, X., Yang, Z., Wang, B., Gong, H., Zhang, K., Lin, Y., & Sun, M. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00453-6 · Cited by 55
Keifer, J. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25022 · Cited by 57
Winston, C. N., Goetzl, E. J., Baker, L. D., Vitiello, M. V., & Rissman, R. A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180302 · Cited by 54
Self-citationKhan, N. A., Asim, M., El-Menyar, A. A., Biswas, K. H., Rizoli, S. B., & Al-Thani, H. A. S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.933434 · Cited by 52
Extracellular vesicles: translational research and applications in neurology
Manolopoulos, A., Yao, P. J., & Kapogiannis, D. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01080-z · Cited by 60
Self-citationExtracellular vesicles in neurodegenerative diseases: Insights and new perspectives
Yuan, Q., Li, X., Zhang, S.-M., Wang, H., & Wang, Y. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.12.001 · Cited by 60
Hampel, H. J., Vergallo, A., Caraci, F., Cuello, A. C., Lemercier, P., Vellas, B. J., Giudici, K. V., Baldacci, F., Hänisch, B., Haberkamp, M., et al. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108081 · Cited by 52
Li, T., Yao, Y., Jiang, X., Dong, Q., Yu, X., Wang, T., Cai, Y., & Han, Y. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01010-x · Cited by 52
Deficient neurotrophic factors of CSPG4‐type neural cell exosomes in Alzheimer disease
Goetzl, E. J., Nogueras‐Ortiz, C. J., Mustapić, M., Mullins, R. J., Abner, E. L., Schwartz, J. B., & Kapogiannis, D. (2018) · The FASEB Journal · doi:10.1096/fj.201801001 · Cited by 48
Self-citationHampel, H. J., Goetzl, E. J., Kapogiannis, D., Lista, S., & Vergallo, A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00310 · Cited by 47
Self-citationRecent advances in optical label‐free characterization of extracellular vesicles
Imanbekova, M., Suarasan, S., Lu, Y. P., Jurchuk, S., & Wachsmann‐Hogiu, S. (2022) · Nanophotonics · doi:10.1515/nanoph-2022-0057 · Cited by 47
Circulating extracellular vesicles: friends and foes in neurodegeneration
Calvani, R., Picca, A., Guerra, F., Coelho-Júnior, H. J., Bucci, C., & Marzetti, E. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.320972 · Cited by 48
Brain Exosomes: Friend or Foe in Alzheimer’s Disease?
Kaur, S., Verma, H., Dhiman, M., Tell, G., Gigli, G. L., Janes, F., & Mantha, A. K. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02547-y · Cited by 45
Soldan, A., Moghekar, A., Walker, K. A., Pettigrew, C. A., Hou, X., Lu, H., Miller, M. I., Alfini, A. J., Albert, M., Xu, D., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00132 · Cited by 45
Dufort‐Gervais, J., Provost, C., Charbonneau, L., Norris, C. M., Calon, F., Mongrain, V., & Brouillette, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-63255-6 · Cited by 48
Li, Z., Moniruzzaman, M., Dastgheyb, R. M., Yoo, S., Wang, M., Hao, H., Liu, J., Casaccia, P., Nogueras‐Ortiz, C. J., Kapogiannis, D., et al. (2020) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12035 · Cited by 45
Self-citationExtracellular Vesicles at CNS barriers: Mode of action
Krämer‐Albers, E. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102569 · Cited by 47
Biomarker and therapeutic potential of peripheral extracellular vesicles in Alzheimer’s disease
Vandendriessche, C., Kapogiannis, D., & Vandenbroucke, R. E. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114486 · Cited by 44
Self-citationHuang, X., Liu, B., Guo, S., Guo, W., Liao, K., Hu, G., Shi, W., Kuss, M. A., Duryee, M. J., Anderson, D. R., et al. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10420 · Cited by 43
Exosome-based approaches in the management of Alzheimer’s disease
Kandimalla, R., Saeed, M., Tyagi, N., Gupta, R. C., & Aqil, F. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104974 · Cited by 45
Boiten, W., van Steenoven, I., Xiao, M.-F., Worley, P., Noli, B., Cocco, C., Ferri, G.-L., Lemstra, A., & Teunissen, C. (2020) · Cells · doi:10.3390/cells10010038 · Cited by 42
Platelets, Protean Cells with All-Around Functions and Multifaceted Pharmacological Applications
Puricelli, C., Boggio, E. M., Gigliotti, C. L., Stoppa, I., Sutti, S., Giordano, M., Dianzani, U., & Rolla, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054565 · Cited by 49
Perrotte, M., Haddad, M., Page, A. Y. L., Frost, E. H., Fülöp, T., & Ramassamy, C. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.10.010 · Cited by 42
Haddad, M., Perrotte, M., Khedher, M. R. B., Demongin, C., Page, A. Y. L., Fülöp, T., & Ramassamy, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194906 · Cited by 41
Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers
Camporesi, E., Lashley, T., Gobom, J., Lantero‐Rodriguez, J., Hansson, O., Zetterberg, H., Blennow, K., & Becker, B. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01119-4 · Cited by 43
Extracellular vesicles in Alzheimer’s disease: from pathology to therapeutic approaches
Thakor, A., & Garcia-Contreras, M. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.343882 · Cited by 41
Lista, S., Santos‐Lozano, A., Emanuele, E., Mercuri, N. B., Gabelle, A., López‐Ortiz, S., Martín-Hernández, J., Maisto, N., Imbimbo, C., Caraci, F., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-023-02376-6 · Cited by 44
Nielsen, J. E., Pedersen, K. S., Vestergård, K., Maltesen, R. G., Christiansen, G., Lundbye‐Christensen, S., Moos, T., Kristensen, S. R., & Pedersen, S. (2020) · Biomedicines · doi:10.3390/biomedicines8070199 · Cited by 39
Bodart‐Santos, V., Pinheiro, L. S., da Silva‐Junior, A. J., Frozza, R. L., Ahrens, R., Gonçalves, R. A., Andrade, M. M., Chen, Y., Alcantara, C. D. L., Grinberg, L. T., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13134 · Cited by 39
Endosomal dysfunction impacts extracellular vesicle release: Central role in Aβ pathology
Arbo, B. D., Cechinel, L. R., Palazzo, R. P., & Siqueira, I. R. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.101006 · Cited by 40
Extracellular vesicles, new actors in the search for biomarkers of dementias
Gámez‐Valero, A., Beyer, K., & Borràs, F. E. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.10.006 · Cited by 38
Biomarkers: Our Path Towards a Cure for Alzheimer Disease
Tarawneh, R. M. (2020) · Biomarker Insights · doi:10.1177/1177271920976367 · Cited by 42
A geroscience motivated approach to treat Alzheimer’s disease: Senolytics move to clinical trials
Gonzales, M. M., Krishnamurthy, S., Garbarino, V. R., Daeihagh, A. S., Gillispie, G. J., Deep, G., Craft, S., & Orr, M. E. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111589 · Cited by 37
Wang, X., Yang, H., Liu, C., & Liu, K. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1194210 · Cited by 36
Longobardi, A., Benussi, L., Nicsanu, R., Bellini, S., Ferrari, C., Saraceno, C., Zanardini, R., Catania, M., Fede, G. D., Squitti, R., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.667369 · Cited by 36
Kumar, A., Sharma, M., Su, Y., Singh, S., Hsu, F., Neth, B. J., Register, T. C., Blennow, K., Zetterberg, H., Craft, S., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac262 · Cited by 37
Wen, C., Ma, H., Xu, L., Gu, Z., Li, H., Zhang, Y., Liang, Y., & Xu, X. G. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002518 · Cited by 37
Kim, K. Y., Shin, K. Y., & Chang, K. (2021) · Biomolecules · doi:10.3390/biom11070980 · Cited by 36
Mesenchymal Stem Cell-Derived Exosomes as a Neuroregeneration Treatment for Alzheimer’s Disease
Shah, S., Mansour, H. M., Aguilar, T. M., & Lucke-Wold, B. P. (2024) · Biomedicines · doi:10.3390/biomedicines12092113 · Cited by 37
Neuronal pentraxin 1: A synaptic-derived plasma biomarker in Alzheimer's disease
Ma, Q., Teng, E., Zuo, X., Jones, M. R., Teter, B., Zhao, E. Y., Zhu, C., Bilousova, T. V., Gylys, K. H., Apostolova, L. G., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.02.014 · Cited by 34
Olivero, G., Cisani, F., Marimpietri, D., Paolo, D. D., Gagliani, M. C., Podestà, M., Cortese, K., & Pittaluga, A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.670158 · Cited by 29
Metadata
- Authors
- Goetzl, E. J., Abner, E. L., Jicha, G. A., Kapogiannis, D., & Schwartz, J. B.
- Affiliations
- University of California, San Francisco (US)
- University of Kentucky (US)
- National Institute on Aging (US)
- Corresponding author
- Goetzl, Edward J.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2018-01-04
- Volume
- 32
- Issue
- 2
- Pages
- 888-893
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC5888398
- OpenAlex
- W2761598264
- Cited by
- 219
- References
- 28
- Citations by year
- 2026: 11 · 2025: 25 · 2024: 29 · 2023: 27 · 2022: 38 · 2021: 30 · 2020: 21 · 2019: 26 · 2018: 12
- FWCI
- 11.94
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- The FASEB Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (P30AG028383)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, plasma biomarkers, NPTX2, neuroligin-1, excitatory synapses, cognitive decline, disease progression, preclinical Alzheimer's disease, synaptic proteins
- MeSH terms
- Pentraxins, Aged, Alzheimer Disease, C-Reactive Protein, Female, Humans, Male, Nerve Tissue Proteins, Neurons, Synaptic Membranes, Cell Adhesion Molecules, Neuronal, Receptors, AMPA, Exosomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review